Renaissance Technologies LLC boosted its position in Trupanion, Inc. (NASDAQ:TRUP – Free Report) by 550.0% during the first quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 39,000 shares of the financial services provider’s stock after buying an additional 33,000 shares during the quarter. Renaissance Technologies LLC’s holdings in Trupanion were worth $999,000 as of its most recent filing with the SEC.
Several other institutional investors have also recently bought and sold shares of the company. Parallel Advisors LLC boosted its position in Trupanion by 1,831.9% during the 1st quarter. Parallel Advisors LLC now owns 1,816 shares of the financial services provider’s stock worth $47,000 after acquiring an additional 1,722 shares during the last quarter. Kemnay Advisory Services Inc. bought a new stake in shares of Trupanion in the fourth quarter worth $64,000. Kelleher Financial Advisors bought a new stake in shares of Trupanion in the third quarter worth $74,000. Advisory Services Network LLC bought a new stake in shares of Trupanion in the third quarter worth $160,000. Finally, Fifth Third Bancorp boosted its holdings in Trupanion by 2,911.1% during the first quarter. Fifth Third Bancorp now owns 7,588 shares of the financial services provider’s stock worth $194,000 after purchasing an additional 7,336 shares during the last quarter.
Trupanion Price Performance
NASDAQ:TRUP opened at $30.60 on Friday. Trupanion, Inc. has a 1-year low of $21.16 and a 1-year high of $49.90. The company has a current ratio of 1.77, a quick ratio of 1.77 and a debt-to-equity ratio of 0.24. The firm has a fifty day simple moving average of $25.56 and a 200 day simple moving average of $26.11. The stock has a market capitalization of $1.34 billion, a PE ratio of 57.74, a P/E/G ratio of 2.23 and a beta of 1.39.
Analyst Ratings Changes
A number of research analysts recently weighed in on TRUP shares. Atlantic Securities set a $42.00 target price on shares of Trupanion in a research report on Wednesday, July 15th. Weiss Ratings raised shares of Trupanion from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Wednesday. Stifel Nicolaus set a $28.00 price objective on shares of Trupanion in a research note on Friday, June 26th. Finally, Zacks Research upgraded Trupanion from a “hold” rating to a “strong-buy” rating in a report on Friday, July 24th. One research analyst has rated the stock with a Strong Buy rating, two have given a Buy rating and three have given a Hold rating to the company. According to data from MarketBeat, Trupanion presently has an average rating of “Moderate Buy” and an average price target of $41.60.
Check Out Our Latest Research Report on TRUP
Insider Activity
In other news, COO John R. Gallagher sold 3,603 shares of the business’s stock in a transaction dated Thursday, May 28th. The shares were sold at an average price of $21.69, for a total transaction of $78,149.07. Following the transaction, the chief operating officer directly owned 33,065 shares in the company, valued at $717,179.85. The trade was a 9.83% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, CEO Margaret Tooth sold 978 shares of the company’s stock in a transaction dated Tuesday, August 11th. The shares were sold at an average price of $29.05, for a total transaction of $28,410.90. Following the completion of the sale, the chief executive officer directly owned 175,401 shares in the company, valued at approximately $5,095,399.05. The trade was a 0.55% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last 90 days, insiders sold 18,785 shares of company stock worth $422,862. Insiders own 5.58% of the company’s stock.
About Trupanion
Trupanion, Inc is a pet medical insurance company that provides comprehensive insurance coverage for cats and dogs. The company’s core offering is a single, customizable medical policy designed to cover veterinary diagnostic tests, surgeries, hospital stays and congenital or hereditary conditions. Trupanion seeks to streamline the claims process by offering direct payment options to participating veterinarians, reducing the need for upfront payments by pet owners.
Founded in 1999 by Darryl Rawlings and headquartered in Seattle, Washington, Trupanion began operations in the early 2000s and has grown its presence through both digital channels and partnerships with veterinary hospitals.
Read More
- Five stocks we like better than Trupanion
- Sony and TSMC’s $4.7 Billion Venture Is About More Than Camera Sensors
- Quantum Leaps: Debt-Free as AI Storage Demand Accelerates
- NVIDIA’s $500 Billion GPU Financing Deal Fuels Path Toward $270
- Sandisk’s Margins Look Like Software. Can They Last?
Want to see what other hedge funds are holding TRUP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Trupanion, Inc. (NASDAQ:TRUP – Free Report).
Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.
